Navigation Links
Schering-Plough Announces Sponsorship of Rabies-Control Projects in India
Date:11/2/2009

trol.net/">www.rabiescontrol.net)

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this press release includes certain "forward-looking statements" within the meaning of the private Securities Litigation Reform Act of 1995, including statements related to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A "Risk Factors" in the Company's third Quarter 2009 10-Q, filed October 29, 2009.

SOURCE Schering-Plough Corporation


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. WuXi AppTec Receives 2009 Schering-Plough Excellence Award
2. Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features In Adults
3. Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of CLARINEX(R)
4. Schering-Plough to Webcast Special Meeting of Shareholders
5. Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck
6. New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus
7. Schering-Plough Announces European Filing of SYCREST(R) (asenapine) for the Treatment of Schizophrenia and Bipolar I Disorder
8. Valeant Grants Schering-Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal
9. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
10. Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males
11. Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... ... 5:00 to 8:00 pm at the Marriott Indianapolis Downtown, 350 West Maryland Street, ... will be attending from across the country. All specialties will be represented. Attendees ...
(Date:9/1/2015)... ... September 01, 2015 , ... Situations requiring fast, easy-to-understand business ... most convenient time for everyone involved. These occasions highlight the value of a ... Services has real people available to handle any translation assignment at any ...
(Date:9/1/2015)... ... September 01, 2015 , ... AdvantagePlusCaregivers.com® provides ... access caregivers and what to look for and expect when searching for resources, ... in 2006 in Canoga Park, CA by CEO, Richard Weatherman and Co-Founder Piroska ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Network, the Premier Outcomes-Driven Provider Network. It is the first-ever, standardized, outcomes-driven ... the provision of quality addiction treatment and the utilization of resources to ...
(Date:9/1/2015)... ... 01, 2015 , ... The integration of Practice Perfect and ... Perfect to FOTO enabling cost and time savings, reducing errors and omissions, and ... of Practice Perfect, stated "FOTO is a natural extension of Practice Perfect, ...
Breaking Medicine News(10 mins):Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:FOTO Announces New Integration Partnership with Practice Perfect 2
... According to a recent study researchers say women who ... risk of stroke // compared to women who do ... study, researchers examined 963 women, 543 of whom had ... loss or migraines with visual lines and spots increased ...
... study, invasive procedures such as catheterization, performed on ... admitted to the hospital may not improve survival ... a statistically significant group of patient population who ... after suffering from suspected acute coronary syndrome, a ...
... patients with Crohn's disease do not have improved bone ... vitamin D therapy. Crohn's is an inflammatory bowel disease ... It usually begins in the teenage years and is ... with Crohn's disease suffer bone mass loss and bone ...
... to lung cancer or chronic obstructive pulmonary disease // later ... study. ,In a recent study done about 123,000 people ... for more than 10 years participated in the study. Results ... many hours a day as children were more than three-times ...
... lower prostate specific antigen levels than men of normal weight. ... may not be as good at identifying early prostate cancer ... no evidence of prostate cancer. Results showed PSA levels declined ... groups and throughout all races. A study done in 2003 ...
... that eating baked or broiled fish, such as tuna, ... study researchers evaluated 4,775 adults 65 and older. Study ... were followed for 12 years. ,Results showed 626 ... strokes. Those who ate broiled or baked fish one- ...
Cached Medicine News:
(Date:9/1/2015)... Sept. 1, 2015  Abbott (NYSE: ABT ) announced ... multi-center, randomized trial comparing the safety and effectiveness of ... ® , Abbott,s market-leading, permanent drug eluting stent. The ... Japan and enrolled 400 people with coronary ... The results will be featured at a late-breaking session ...
(Date:9/1/2015)... Quebec , Sept. 1, 2015  Valeant ... TSX: VRX) today announced that its affiliate has ... which Valeant was granted an exclusive license to ... is an IL-17 receptor monoclonal antibody in development ... arthritis. Under the agreement, Valeant will hold the ...
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
Breaking Medicine Technology:Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
Inquire...
Inquire...
... optical performance, the SZX7 is designed for ... every task, from routine preparations to advanced ... best zoom ratios in its class as ... and accurate reproduction of the original specimen ...
A compact stereomicroscope that is immediately ready for operation and extremely easy to use. Focused on the essential performance features, the Stemi DV4 design concept provides optimum utility....
Medicine Products: